|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: WERNER ENTERPRISES INC, 10-Q, EX-11, 2000-11-14 |
Next: IGENE BIOTECHNOLOGY INC, 10QSB, 2000-11-14 |
<TABLE> <S> <C>
<ARTICLE> 5
<MULTIPLIER> 1,000
<S> <C>
<PERIOD-TYPE> 9-MOS
<FISCAL-YEAR-END> DEC-31-2000
<PERIOD-START> JAN-01-2000
<PERIOD-END> SEP-30-2000
<CASH> 19,416
<SECURITIES> 0
<RECEIVABLES> 131,107
<ALLOWANCES> 0
<INVENTORY> 0
<CURRENT-ASSETS> 201,035
<PP&E> 1,002,222
<DEPRECIATION> 296,918
<TOTAL-ASSETS> 915,262
<CURRENT-LIABILITIES> 105,511
<BONDS> 0
0
0
<COMMON> 483
<OTHER-SE> 524,486
<TOTAL-LIABILITY-AND-EQUITY> 915,262
<SALES> 903,193
<TOTAL-REVENUES> 903,193
<CGS> 0
<TOTAL-COSTS> 841,197
<OTHER-EXPENSES> (1,556)
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 6,256
<INCOME-PRETAX> 57,296
<INCOME-TAX> 21,772
<INCOME-CONTINUING> 35,524
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> 35,524
<EPS-BASIC> .75
<EPS-DILUTED> .75
</TABLE>
|
|